Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

MicroRNAs as biomarkers for clinical studies

(2017) Igor P Pogribny   EXPERIMENTAL BIOLOGY AND MEDICINE

Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation

(2017) David Goldberg et al.   GASTROENTEROLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Use of Liver Imaging and Biopsy in Clinical Practice

(2017) Elliot B. Tapper et al.   NEW ENGLAND JOURNAL OF MEDICINE

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

(2017) Mireia López-Riera et al.   Frontiers in Pharmacology

Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma

(2016) Norio Akuta et al.   BMC GASTROENTEROLOGY

Combination of let-7d-5p, miR-26a-5p, and miR-15a-5p is suitable normalizer for studying microRNA expression in skin tissue of Liaoning cashmere goat during hair follicle cycle

(2016) W.L. Bai et al.   CZECH JOURNAL OF ANIMAL SCIENCE

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan

(2016) Norio Akuta et al.   Hepatology International

Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications

(2016) S. Di Mauro et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease

(2016) Noel C. Salvoza et al.   PLoS One

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers

(2016) Juan M. Fernandez-Costa et al.   PLoS One

Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population

(2016) Xiao-Lin Liu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study

(2015) Amir Zarrinpar et al.   GUT

miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR

(2015) CHUANZHENG SUN et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

RUCAM in Drug and Herb Induced Liver Injury: The Update

(2015) Gaby Danan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

(2015) Philip P. Becker et al.   PLoS One

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

(2014) Carlos J Pirola et al.   GUT

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma

(2014) Anna Wojcicka et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases

(2014) Christoph Roderburg et al.   LIVER INTERNATIONAL

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease

(2014) Youwen Tan et al.   PLoS One

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver

(2013) Hiroya Yamada et al.   CLINICA CHIMICA ACTA

Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease

(2013) Hisamitsu Miyaaki et al.   LIVER INTERNATIONAL

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

MiR-122 in hepatic function and liver diseases

(2012) Jun Hu et al.   Protein & Cell

PolyA RT-PCR-based quantification of microRNA by using universal TaqMan probe

(2011) Xin Luo et al.   BIOTECHNOLOGY LETTERS

Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

(2011) Silvia Cermelli et al.   PLoS One

Haemolysis during Sample Preparation Alters microRNA Content of Plasma

(2011) Michaela B. Kirschner et al.   PLoS One

Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity?

(2010) Swanhild U. Meyer et al.   BIOTECHNOLOGY LETTERS

Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues

(2008) H. J. Peltier et al.   RNA